• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr John Ward on Conversations With Patients After Multigene Testing

Video

Multigene testing provides a lot of information that providers have to be familiar with in order to adequately explain it to their patients, said John H. Ward, MD, Huntsman Cancer Institute at the University of Utah.

Multigene testing provides a lot of information that providers have to be familiar with in order to adequately explain it to their patients, said John H. Ward, MD, Huntsman Cancer Institute at the University of Utah.

Transcript

How does multigene testing change conversations between patients and providers?

I don’t think it’s changed much, because they’ve been available for a long time. I think there’s a lot of information there, and it requires being familiar with the assays so you can make sense of them to the patient, telling them how they’ve been tested, how to interpret the data. Two of the companies that have recently changed their reports, which make them much more easy to use and explain to patients the benefits or lack of benefits, and I applaud their decision to simplify things.

Related Videos
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Screenshot of Joshua Meeks, MD, PhD, during a video interview
Screenshot of Neal Shore, MD, in a video interview
Darius Lakdawalla, PhD, director of research, USC Schaeffer Center
Screenshot of Ryan Nix, PharmD, during a video interview
Screenshot of Fran Gregory, PharmD, MBA, during a video interview
dr martin dahl
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.